CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 55 filers reported holding CONCERT PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $664,872 | +510.0% | 113,848 | +339.6% | 0.00% | – |
| Q2 2022 | $109,000 | -0.9% | 25,901 | -20.4% | 0.00% | – |
| Q1 2022 | $110,000 | -23.1% | 32,547 | -28.2% | 0.00% | – |
| Q4 2021 | $143,000 | +62.5% | 45,319 | +67.7% | 0.00% | – |
| Q3 2021 | $88,000 | -34.3% | 27,023 | -14.8% | 0.00% | – |
| Q2 2021 | $134,000 | -61.0% | 31,727 | -53.9% | 0.00% | – |
| Q1 2021 | $344,000 | -53.1% | 68,829 | +18.5% | 0.00% | -100.0% |
| Q4 2020 | $734,000 | +33.2% | 58,073 | +3.6% | 0.00% | 0.0% |
| Q3 2020 | $551,000 | +70.1% | 56,069 | +72.0% | 0.00% | – |
| Q2 2020 | $324,000 | +31.2% | 32,591 | +16.7% | 0.00% | – |
| Q1 2020 | $247,000 | -33.8% | 27,932 | -30.9% | 0.00% | – |
| Q4 2019 | $373,000 | +58.1% | 40,431 | +0.9% | 0.00% | – |
| Q3 2019 | $236,000 | -61.4% | 40,077 | -21.4% | 0.00% | -100.0% |
| Q2 2019 | $612,000 | +17.5% | 50,969 | +18.1% | 0.00% | 0.0% |
| Q1 2019 | $521,000 | -5.8% | 43,157 | -2.1% | 0.00% | 0.0% |
| Q4 2018 | $553,000 | -44.1% | 44,072 | -33.9% | 0.00% | 0.0% |
| Q3 2018 | $989,000 | -0.5% | 66,641 | +12.8% | 0.00% | 0.0% |
| Q2 2018 | $994,000 | -7.4% | 59,063 | +26.0% | 0.00% | 0.0% |
| Q1 2018 | $1,073,000 | -59.9% | 46,867 | -54.7% | 0.00% | -75.0% |
| Q4 2017 | $2,675,000 | -39.9% | 103,417 | -65.7% | 0.00% | -42.9% |
| Q3 2017 | $4,452,000 | +1.1% | 301,836 | -4.4% | 0.01% | 0.0% |
| Q2 2017 | $4,404,000 | -12.0% | 315,729 | +7.6% | 0.01% | -22.2% |
| Q1 2017 | $5,004,000 | +734.0% | 293,303 | +403.2% | 0.01% | +800.0% |
| Q4 2016 | $600,000 | +46.7% | 58,288 | +43.9% | 0.00% | 0.0% |
| Q3 2016 | $409,000 | +46.6% | 40,503 | +63.2% | 0.00% | 0.0% |
| Q2 2016 | $279,000 | – | 24,811 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 2,610 | $620,000,000 | 6.47% |
| Parkman Healthcare Partners LLC | 1,124,072 | $4,732,000 | 1.74% |
| Kynam Capital Management, LP | 1,000,000 | $4,210,000 | 1.08% |
| EAM Investors, LLC | 850,647 | $3,581,000 | 0.87% |
| BVF INC/IL | 3,629,000 | $15,278,000 | 0.74% |
| EAM Global Investors LLC | 388,730 | $1,637,000 | 0.40% |
| RA Capital Management | 3,307,203 | $13,923,000 | 0.37% |
| Nantahala Capital Management | 1,659,840 | $6,988,000 | 0.35% |
| AWM Investment Company, Inc. | 504,661 | $2,125,000 | 0.34% |
| INGALLS & SNYDER LLC | 1,411,153 | $5,941,000 | 0.31% |